Koninklijke Philips reported EUR7.42B in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Abbott USD 16.15B 1.66B Sep/2026
Baxter International USD 3.81B 218M Sep/2026
Becton, Dickinson and Co. USD 9.54B 139M Sep/2026
Boston Scientific USD 5.98B 446M Sep/2026
Danaher USD 9.05B 945M Sep/2026
Demant DKK 12.42B 5B Jun/2026
Dexcom USD 2.25B 105.1M Sep/2026
Edwards Lifesciences USD 1.58B 68.8M Sep/2026
Fresenius EUR 8.08B 986M Sep/2026
General Electric Aerospace USD 42.4B 1.96B Sep/2026
Getinge SEK 12.03B 3.01B Jun/2026
Globus Medical USD 507.94M 28.59M Sep/2026
GN Store Nord DKK 10.82B 4.86B Sep/2026
Hitachi JPY 7.34T 175.94B Sep/2026
Idexx Laboratories USD 1.26B 23.44M Sep/2026
Insulet USD 814.4M 70.2M Sep/2026
Integra LifeSciences USD 329M 1.88M Sep/2026
Intuitive Surgical USD 3.23B 652.4M Sep/2026
J&J USD 55.46B 562M Sep/2026
Koninklijke Philips EUR 7.42B 9M Jun/2026
Medtronic USD 11.8B 141M Jun/2026
Philips EUR 7.91B 485M Sep/2026
ResMed USD 1.32B 70.89M Sep/2026
Smith & Nephew USD 2.05B 510M Jun/2026
Steris USD 1.21B 75.5M Sep/2026
Stryker USD 6.5B 184M Sep/2026
Teleflex USD 917.1M 196.72M Sep/2026
Terumo JPY 306.08B 107.19B Sep/2026
Zimmer Biomet Holdings USD 3.5B 488.9M Sep/2026